Sal Pharma

FDA
Manufacturing

FDA slams Indian API firm for faking certificates of analysis

A recent report says that FDA inspections of Indian drugmakers tripled between 2010 and 2015, and that trend continues this year, with the latest to feel the heat being Sal Pharma.
Eric Palmer May 3, 2017 8:28am